Financhill
Back

Structure Therapeutics Vs. Amgen Industry Stock Comparison

Sell
36

GPCR
Structure Therapeutics

Last Price:
39.63
Seasonality Move:
-19.39%
Sell
39

AMGN
Amgen

Last Price:
321.45
Seasonality Move:
10.18%
Sell
36
Structure Therapeutics (GPCR) is a Sell

Is Structure Therapeutics a Buy, Sell or Hold?

  • The current Structure Therapeutics [GPCR] share price is $38.99. The Score for GPCR is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • GPCR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Amgen (AMGN) is a Sell

Is Amgen a Buy, Sell or Hold?

  • The current Amgen [AMGN] share price is $321.63. The Score for AMGN is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • AMGN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GPCR Stock Price Chart

What is Structure Therapeutics's stock price today?

  • The Structure Therapeutics share price today is $38.99
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GPCR is experiencing buying pressure, which is a positive indicator for future bullish movement.

AMGN Stock Price Chart

What is Amgen's stock price today?

  • The Amgen share price today is $321.63
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AMGN is experiencing selling pressure, which indicates risk of future bearish movement.

GPCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.45 Sell
Relative Strength Index (14 RSI): 47.46 Sell
Chaikin Money Flow: 498645 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.5 - 42.7) Sell
Bollinger Bands (100): (35.36 - 45.62) Sell

AMGN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.17 Sell
Relative Strength Index (14 RSI): 46.84 Sell
Chaikin Money Flow: -1465766 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (318.47 - 332.39) Sell
Bollinger Bands (100): (310.43 - 332.37) Buy

GPCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 38.77 Buy
20-day SMA: 40.86 Sell
50-day SMA: 39.04 Sell
200-day SMA: 40.58 Sell
8-day EMA: 38.79 Buy
20-day EMA: 39.74 Sell
50-day EMA: 39.68 Sell
200-day EMA: 39.82 Sell

AMGN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 322.27 Sell
20-day SMA: 323.61 Sell
50-day SMA: 325.74 Sell
200-day SMA: 305.75 Buy
8-day EMA: 322.93 Sell
20-day EMA: 323.63 Sell
50-day EMA: 324.18 Sell
200-day EMA: 306.41 Buy

Structure Therapeutics Earnings Growth & GPCR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.13 per share, and an increase next year of $0.07 per share.

Amgen Earnings Growth & AMGN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.97 per share, and an increase next year of $1.12 per share.

Structure Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Amgen Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):